
Truveta
Founded Year
2020Stage
Series C | AliveTotal Raised
$515MValuation
$0000Last Raised
$320M | 6 mos agoMosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
+98 points in the past 30 days
About Truveta
Truveta provides electronic health record (EHR) data and analytics within the healthcare sector. The company offers EHR data, including clinical notes and images, linked with social determinants of health, mortality, and claims data for research and development purposes. Truveta's solutions are used by life science, government, academic, health system, and research entities. It was founded in 2020 and is based in Bellevue, Washington.
Loading...
ESPs containing Truveta
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The electronic health record (EHR) integrators market is focused on addressing the challenge of fragmented data across applications and systems in the healthcare industry. These integrators aim to improve interoperability by enabling patient data access and sharing between systems, reducing errors and improving the quality of care. The market is relevant to both payers and providers, who adopt EHR…
Truveta named as Highflier among 15 other companies, including Iron Mountain, Veradigm, and Innovaccer.
Loading...
Research containing Truveta
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Truveta in 3 CB Insights research briefs, most recently on Apr 17, 2025.

Apr 17, 2025 report
State of Digital Health Q1’25 Report
Aug 21, 2024
The clinical trials tech market mapExpert Collections containing Truveta
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Truveta is included in 4 Expert Collections, including Unicorns- Billion Dollar Startups.
Unicorns- Billion Dollar Startups
1,256 items
Digital Health
11,375 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Digital Health 50
150 items
2022's cohort of the most promising digital health startups transforming the healthcare industry. Winners were chosen based on several factors, including data submitted by the companies, proprietary Mosaic scores, company business models and momentum in the market.
Artificial Intelligence
9,906 items
Truveta Patents
Truveta has filed 7 patents.
The 3 most popular patent topics include:
- health informatics
- electronic health records
- information privacy

Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
11/8/2022 | Health informatics, Electronic health records, Telehealth, Medical terminology, Information privacy | Application |
Application Date | 11/8/2022 |
---|---|
Grant Date | |
Title | |
Related Topics | Health informatics, Electronic health records, Telehealth, Medical terminology, Information privacy |
Status | Application |
Latest Truveta News
Apr 16, 2025
As depression becomes more common in the US, treatment rates vary, CDC reports show By Deidre McPhillips and Jen Christensen, CNN (CNN) — Depression is becoming more common among adults and adolescents in the United States, but most are not getting therapy to help, according to a new report from the US Centers for Disease Control and Prevention. More than 1 in 8 people ages 12 and up in the US have been depressed in recent years, according to data published Wednesday by the CDC’s National Center for Health Statistics. Depression prevalence has nearly doubled, from 7.3% in 2015-16 to more than 13% in 2021-23. The findings are based on results from a federal survey – most recently conducted between August 2021 and August 2023 – in which participants reported whether they had had certain symptoms associated with depression in the previous two weeks. Responses to these validated screening questions were scored to determine whether the individuals had depression. The Covid-19 pandemic interrupted the administration of the survey, and modifications that were made once it resumed – including changes to the way it was administered – may have affected the ability to most accurately track changes over time. People are less likely to report conditions that could potentially be considered socially undesirable in face-to-face interviews than they are in phone or online interviews, and changes in that method could account for increases, Dr. Renee Goodwin, a psychiatric epidemiologist and clinical psychologist with Columbia University, told CNN. Still, experts have long said that the pandemic exacerbated mental health challenges for many in the US – 90% of adults have said that the country is facing a mental health crisis, according to a 2022 survey from CNN in partnership with KFF – but experts have also said that awareness around mental health has grown. Dr. Matt Mishkind, deputy director of the Johnson Depression Center at the University of Colorado Anschutz Medical Campus, says that researchers have been trying to figure out why depression rates have been growing for the past decade or so – and at least part of it has to do with decreasing stigma around talking about mental health in some groups. “The question then is, has that truly increased, or have we just been able to identify it more? I definitely think it has increased, and I think that’s because I think the world is a difficult place right now,” he said. “I think there’s been stressor after stressor after stressor for a long time now, and I think that is starting to truly affect people.” According to the new CDC data, women are more likely than men to have depression, and prevalence tends to decrease with age and greater wealth. Overall, about 16% of women and 10% of men had depression during the 2021-23 survey period. But more than 1 in 4 adolescent girls between ages 12 and 19 had depression, the data shows, higher than any other demographic group. Data from the CDC’s latest Youth Risk Behavior Survey showed that more than half of high school girls (53%) said they felt persistently sad or hopeless – nearly twice the rate of share of boys (28%) who said the same and 14 percentage points higher than a decade earlier. “Girls are more verbal and vocal about some of their challenges, traditionally; boys are not as much, although I think that is changing,” Dr. Jill Emanuele, vice president of clinical training at the Child Mind Institute in New York City, told CNN in August. She was not involved in any of the CDC reports. Treatment disparities The vast majority of adults and adolescents with depression in the latest survey – nearly 88% – said that symptoms had created difficulties for them in work, at home or with social activities, and about a third of those said it was “very to extremely difficult.” But only about 40% of adults and adolescents with depression received counseling or therapy, the new CDC report shows. Women were more likely than men to have received therapy: about 43%, compared with 33%. Adult women are also more than twice as likely as adult men to take medication for depression, according to another CDC report published Wednesday. In 2023, about 11.4% of US adults took a prescription medication for depression – but that breaks out to more than 15% of women and 7.4% of men. Despite higher rates of depression in younger age groups, the new CDC reports show that middle-age people were more likely than younger adults to take prescription medication for depression. More than 12% of adults between ages 45 and 74 did so in 2023, compared with less than 11% of adults ages 18 to 44. US Department of Health and Human Services Secretary Robert F. Kennedy Jr. has specifically targeted a certain class of antidepressant drugs in recent comments. At his Senate confirmation this year, he falsely suggested that selective serotonin reuptake inhibitors, or SSRIs, may be more addictive than heroin. And the Trump administration’s strategy for the Make America Healthy Again commission – which Kennedy will lead – specifically plans to address an assessment of the “prevalence of and threat posed by the prescription of selective serotonin reuptake inhibitors” for children, along with other mental health medications. But in February, health care data and analytics company Truveta analyzed information from its database of millions of electronic health records to understand whether increased awareness around mental health has led to increases in people seeking medication or concerns around overprescribing or dependency on antidepressant medications. It found that trends in prescriptions for mental health have remained relatively stable since 2018. Rates ticked up in the early years of the Covid-19 pandemic but have since dropped to levels from 2018 or lower. Antidepressants are the most commonly prescribed mental health medication – with SSRIs accounting for nearly half – but Truveta found trends in prescribing rates to be much steadier than the CDC found in trends for depression prevalence. And the findings do not suggest that over-rescribing mental health medications should be a concern. “While increased mental health awareness and the heightened demand for care during the COVID-19 pandemic may have contributed to shifts in prescribing rates, our findings suggest that overall trends in mental health prescriptions have remained relatively stable, with only slight fluctuations in recent years,” Truveta researchers wrote in a blog post. “While there was a slight increase in the rate of mental health prescriptions during the peak years of the COVID-19 pandemic, the subsequent stabilization and decrease suggests that the rise was likely a temporary response to heightened mental health needs rather than a long-term shift toward higher prescribing rates.” The-CNN-Wire
Truveta Frequently Asked Questions (FAQ)
When was Truveta founded?
Truveta was founded in 2020.
Where is Truveta's headquarters?
Truveta's headquarters is located at 1745 114th Avenue South East, Bellevue.
What is Truveta's latest funding round?
Truveta's latest funding round is Series C.
How much did Truveta raise?
Truveta raised a total of $515M.
Who are the investors of Truveta?
Investors of Truveta include Providence, Advocate Health, Illumina, Regeneron, Henry Ford Health System and 9 more.
Who are Truveta's competitors?
Competitors of Truveta include Tasq.ai, Medicom, Atropos Health, Endimension, Dandelion and 7 more.
Loading...
Compare Truveta to Competitors

nference is a healthcare technology company specializing in clinical artificial intelligence (AI) and evidence. The company offers a platform that uses healthcare data to manage clinical data, support research, and work with patient outcomes through artificial intelligence. nference primarily serves the healthcare sector, providing solutions for clinical researchers, data scientists, and healthcare systems. It was founded in 2013 and is based in Cambridge, Massachusetts.

Commure provides artificial intelligence (AI) powered healthcare solutions within the health technology sector. The company offers products that automate and simplify provider, administrator, and patient workflows, including ambient clinical documentation, revenue cycle management, and remote patient monitoring. Commure serves the healthcare industry, with a focus on care delivery and operations for health systems. It was founded in 2017 and is based in Mountain View, California.

Zus Health is a shared health data platform that aims to improve healthcare data interoperability. The company offers the Zus Aggregated Profile, which provides a view of a patient's healthcare interactions, intended for use at the point of care through integrations such as API, embedded components, and direct EHR systems. Zus Health serves healthcare organizations seeking to improve patient data access and care team efficiency. Zus Health was formerly known as Zeus Healthcare Technologies. It was founded in 2020 and is based in Boston, Massachusetts.

Owkin is an AI biotechnology company that employs artificial intelligence to improve drug discovery and development in the biopharmaceutical sector. The company specializes in AI-based identification of new treatments, clinical trial optimization, and diagnostic tool creation, while ensuring patient privacy through federated learning techniques. Owkin serves the biopharma and academic research communities. It was founded in 2016 and is based in New York, New York.

Loopback Analytics specializes in data analytics and insights within the healthcare sector, focusing on simplifying access for patients requiring specialty care. The company offers a platform that enables health systems to manage specialty patients, provides life sciences with data for research, and supports the identification and engagement of nuanced patient and therapy journeys. Loopback Analytics primarily serves the healthcare and life sciences industries with its data-enabled services and analytics platform. Loopback Analytics was formerly known as Loopback Communications. It was founded in 2009 and is based in Dallas, Texas.

iPampas is a technology company that offers private wealth management and alternative investment solutions within the financial services industry. Their main offerings include a unified account solution for family offices and independent asset managers, as well as alternative investment management services. iPampas serves the private wealth management sector, including family offices, independent asset managers, and licensed alternative investment management institutions. It was founded in 2017 and is based in Hangzhou, Zhejiang .
Loading...